Delivery Order SPE2DB20D3103-SPE2DB24FL6J1
Award Date
11/22/23
Potential Completion Date
11/24/23
Potential Value
$6.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Renflexis 100 mg vials. The contract has a ceiling value of $1,242.50 and runs through December 12, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100mg vials of the drug Renflexis. The contract has a ceiling value of $4,039.92 and runs through January 3, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Renflexis 100 mg vials. The contract has a ceiling value of $4,069.16 and a period of performance ending on November 4, 2024. The contract was awarded on November 1, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg vials of the biologic drug Renflexis. The $8,632.74 firm fixed-price contract has a completion date of January 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4557385111 Renflexis 100 mg vials. The single-award Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, serves as the primary vehicle for DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $6,529.60 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564712042 RENFLEXIS 100 MG VIALS. This contract has an ultimate completion date of May 28, 2024 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RENFLEXIS 100 MG VIALS, with a ceiling value of $6,074.10 and a completion date of May 5, 2023. The contract is a firm fixed price, delivery order type, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg vials of the drug Renflexis. The $5,386.56 firm fixed-price contract has an ultimate completion date of August 28, 2023. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,798.40, is for the supply of RENFLEXIS 100 MG VIALS, a specialty pharmaceutical product. The contract has a firm fixed price and runs through October 24, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,797.70, is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The delivery order contract has a firm fixed price pricing type and an ultimate completion date of May 31, 2024. The contract was not set aside for any specific business size or socioeconomic category....